AI assistant
Sending…
Whitehawk Therapeutics, Inc. — Director's Dealing 2017
Dec 18, 2017
34276_dirs_2017-12-18_54e520aa-d1a4-4d20-85d1-e272b6d71a91.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2017-12-14
Reporting Person: HOFFMAN STEPHEN J (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-14 | Stock Option (Right to Buy) | $5.50 | A | 586012 | Acquired | 2027-12-01 | Common Stock (586012) | Direct |
Footnotes
F1: Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.
More from Whitehawk Therapeutics, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Capital/Financing Update
2026
May 13
Report Publication Announcement
2026
May 7
Director's Dealing
2025
Dec 2
Director's Dealing
2025
Dec 2
Regulatory Filings
2025
Nov 6
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Aug 25
Earnings Release
2025
Aug 7